Sign in

CIK 0001339970

  • Non-accelerated filer
  • Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203435077
Phone
+1 858-731-8389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-05-08 MENDLEIN JOHN Director Grant or award · Stock Option (right to buy) +20,000 20,000
2018-12-21 MENDLEIN JOHN Director Purchase +195,000 $0.42 $83K 615,382
2018-12-20 MENDLEIN JOHN Director Purchase +50,000 $0.41 $21K 420,382
2018-05-15 MENDLEIN JOHN Director Grant or award · Stock Option (right to buy) +20,000 20,000
2018-01-02 MENDLEIN JOHN Director Grant or award · Stock Option (right to buy) +32,000 32,000
2017-08-31 MENDLEIN JOHN CEO and Director Purchase +37,736 $2.65 $100K 367,883
2017-08-31 MENDLEIN JOHN CEO and Director Purchase · Warrant to Purchase Common Stock +14,151 14,151
2017-04-24 MENDLEIN JOHN CEO and Director Purchase +124 $3.00 $372 327,647
2017-04-20 MENDLEIN JOHN CEO and Director Purchase +1,552 $3.00 $5K 327,523
2017-04-18 MENDLEIN JOHN CEO and Director Purchase +1,000 $3.00 $3K 325,971
2017-02-07 MENDLEIN JOHN CEO and Director Grant or award · Employee Stock Option (right to buy) +185,000 185,000
2016-12-19 MENDLEIN JOHN CEO and Director Purchase +69,000 $2.20 $152K 324,971
2016-04-05 MENDLEIN JOHN CEO and Director Purchase +2,500 $3.52 $9K 250,971
2016-04-05 MENDLEIN JOHN CEO and Director Purchase +2,500 $3.55 $9K 248,471
2016-01-27 MENDLEIN JOHN CEO and Director Grant or award · Employee Stock Option (right to buy) +135,000 135,000
2016-01-04 MENDLEIN JOHN CEO and Director Grant or award · Employee Stock Option (right to buy) +148,732 148,732
2015-10-01 MENDLEIN JOHN See Remarks Grant or award · Employee Stock Option (right to buy) +71,000 71,000
2015-10-01 MENDLEIN JOHN See Remarks Grant or award · Employee Stock Option (right to buy) +65,070 65,070
2015-05-12 MENDLEIN JOHN CEO and Executive Chairman Conversion +24,055 245,971
2015-05-12 MENDLEIN JOHN CEO and Executive Chairman Conversion · Series C Redeemable Convertible Preferred Stock −170,218 0

Page 1 of 2 · 22 trades